DVS (Dose Verification System), developed by Sicel Technologies, was an implantable telemetric, radiation sensor. [1] The device was used to measure the amount of radiation that was delivered to tumor and/or healthy tissue. The DVS sensor contained a dosimeter and wireless transmitter inside a sealed, biocompatible glass capsule measuring 0.8 inches (20mm) long and 0.08 inches (2.1mm) across. The sensor was implantable transluminally or transdermally. The device had limited adoption by the radiation oncology community, sales were thus inadequate for profitability.
The company (Sicel) eventually ceased to exist circa 2011. [2]
References
- ^ Scarantino, Charles W.; Beyer, Gloria P. (November 2008). "The Dose Verification System (DVS) for cancer patients receiving radiation therapy". Expert Review of Medical Devices. 5 (6): 679–685. doi: 10.1586/17434440.5.6.679. ISSN 1743-4440. PMID 19025343.
- ^ "Sicel Files for Bankruptcy | FDAnews". www.fdanews.com. Retrieved 30 September 2023.
Further reading
DVS (Dose Verification System), developed by Sicel Technologies, was an implantable telemetric, radiation sensor. [1] The device was used to measure the amount of radiation that was delivered to tumor and/or healthy tissue. The DVS sensor contained a dosimeter and wireless transmitter inside a sealed, biocompatible glass capsule measuring 0.8 inches (20mm) long and 0.08 inches (2.1mm) across. The sensor was implantable transluminally or transdermally. The device had limited adoption by the radiation oncology community, sales were thus inadequate for profitability.
The company (Sicel) eventually ceased to exist circa 2011. [2]
References
- ^ Scarantino, Charles W.; Beyer, Gloria P. (November 2008). "The Dose Verification System (DVS) for cancer patients receiving radiation therapy". Expert Review of Medical Devices. 5 (6): 679–685. doi: 10.1586/17434440.5.6.679. ISSN 1743-4440. PMID 19025343.
- ^ "Sicel Files for Bankruptcy | FDAnews". www.fdanews.com. Retrieved 30 September 2023.